论文部分内容阅读
目的评估雾化吸入尖吻蝮蛇血凝酶和凝血酶治疗咯血的疗效和安全性。方法 39例各种原因咯血患者在常规治疗的基础上,加用凝血酶1000U、尖吻蝮蛇血凝酶2IU雾化吸入治疗,2次/d,观察止血效果和止血时间。结果 39例中显效21例,有效16例,无效2例,总有效率为94.87%、平均止血时间分别为2.3±0.31 d;无不良反应。结论雾化吸入尖吻蝮蛇血凝酶和凝血酶治疗咯血起效迅速,疗效确切,安全无痛苦且操作简单。
Objective To evaluate the efficacy and safety of inhalation of Agkistrodon acutus serogroups and thrombin on hemoptysis. Methods Thirty-nine cases of patients with various causes of hemoptysis were treated with 1000U thrombin and 2IU aerosol inhalation on the basis of routine therapy. The hemostatic effect and the bleeding time were observed. Results Among the 39 cases, 21 cases were markedly effective, 16 cases were effective and 2 cases were ineffective. The total effective rate was 94.87%. The average hemostatic time was 2.3 ± 0.31 days respectively. There was no adverse reaction. Conclusion Inhalation inhalation of Agkistrodon acutus serogroups and thrombin treatment of hemoptysis rapid onset, the exact effect, safe and painless and easy to operate.